(Q72586552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

complement system proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

1

L M Nadler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

T. Takvorian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

L. Botnick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

R. C. Bast

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

R. Finberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

S. Hellman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

G. P. Canellos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

S. F. Schlossman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6147502

14 August 2023

language of work or name

English

0 references

publication date

1 August 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

25 August 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6147502

full work available at URL

14 August 2023

https://api.elsevier.com/content/article/PII:S0140673684929076?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

https://api.elsevier.com/content/article/PII:S0140673684929076?httpAccept=text/plain

14 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

14 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

427-431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Role of massive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Sequential pathologic staging of untreated non-Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Frequencies and patterns of bone marrow involvement in non-hodgkin lymphomas: Observations on the value of bilateral biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Incidence, cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Nodular lymphoma: Bone marrow and blood manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

A unique cell surface antigen identifying lymphoid malignancies of B cell origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

The delineation of antigen receptors on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Autologous bone-marrow transplantation: host effects of high-dose BCNU

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992907-6

7 January 2021

Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites

1

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas

14 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement

14 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

Bone Marrow Transplantation in Cancer Therapy: Inactivation by Antibody and Complement of Tumor Cells in Mouse Syngeneic Marrow Transplants

14 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

Elimination of leukemic cells from rat bone marrow using antibody and complement

14 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)92907-6

14 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6147502%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference